Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |